|
1
|
Galiè N, Humbert M, Vachiery JL, Gibbs S,
Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A,
Beghetti M, et al: 2015 ESC/ERS guidelines for the diagnosis and
treatment of pulmonary hypertension: The joint task force for the
diagnosis and treatment of pulmonary hypertension of the European
society of cardiology (ESC) and the European respiratory society
(ERS): Endorsed by: Association for European paediatric and
congenital cardiology (AEPC), international society for heart and
lung transplantation (ISHLT). Eur Heart J. 37:67–119.
2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Matura LA, McDonough A and Carroll DL:
Symptom prevalence, symptom severity, and health-related quality of
life among young, middle, and older adults with pulmonary arterial
hypertension. Am J Hosp Palliat Care. 33:214–221. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Heyworth IT, Hazell ML, Linehan MF and
Frank TL: How do common chronic conditions affect health-related
quality of life. Br J Gen Pract. 59:e353–e358. 2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Shafazand S, Goldstein MK, Doyle RL,
Hlatky MA and Gould MK: Health-related quality of life in patients
with pulmonary arterial hypertension. Chest. 126:1452–1459.
2004.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Batal O, Khatib OF, Bair N, Aboussouan LS
and Minai OA: Sleep quality, depression, and quality of life in
patients with pulmonary hypertension. Lung. 189:141–149.
2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Rubenfire M, Lippo G, Bodini BD, Blasi F,
Allegra L and Bossone E: Evaluating health-related quality of life,
work ability, and disability in pulmonary arterial hypertension: An
unmet need. Chest. 136:597–603. 2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chua R, Keogh AM, Byth K and O'Loughlin A:
Comparison and validation of three measures of quality of life in
patients with pulmonary hypertension. Intern Med J. 36:705–710.
2006.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Larisch A, Neeb C, de Zwaan M, Pabst C,
Tiede H, Ghofrani A, Olsson K, Hoeper M and Kruse J: Mental
distress and wish for psychosomatic treatment of patients with
pulmonary hypertension. Psychother Psychosom Med Psychol.
64:384–389. 2014.(In German). PubMed/NCBI View Article : Google Scholar
|
|
9
|
Löwe B, Gräfe K, Ufer C, Kroenke K, Grünig
E, Herzog W and Borst MM: Anxiety and depression in patients with
pulmonary hypertension. Psychosom Med. 66:831–836. 2004.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Harzheim D, Klose H, Pinado FP, Ehlken N,
Nagel C, Fischer C, Ghofrani A, Rosenkranz S, Seyfarth HJ, Halank
M, et al: Anxiety and depression disorders in patients with
pulmonary arterial hypertension and chronic thromboembolic
pulmonary hypertension. Respir Res. 14(104)2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Halank M, Einsle F, Lehman S, Bremer H,
Ewert R, Wilkens H, Meyer FJ, Grünig E, Seyfarth HJ, Kolditz M, et
al: Exercise capacity affects quality of life in patients with
pulmonary hypertension. Lung. 191:337–343. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Flattery MP, Pinson JM, Savage L and
Salyer J: Living with pulmonary artery hypertension: Patients'
experiences. Heart Lung. 34:99–107. 2005.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cicero C, Franchi SM, Barreto AC and Lopes
AA: Lack of tight association between quality of life and exercise
capacity in pulmonary arterial hypertension. Arq Bras Cardiol.
99:876–885. 2012.(In English, Portuguese). PubMed/NCBI View Article : Google Scholar
|
|
14
|
McCabe C, Bennett M, Doughty N, MacKenzie
Ross R, Sharples L and Pepke-Zaba J: Patient-reported outcomes
assessed by the CAMPHOR questionnaire predict clinical
deterioration in idiopathic pulmonary arterial hypertension and
chronic thromboembolic pulmonary hypertension. Chest. 144:522–530.
2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Nagel C, Prange F, Guth S, Herb J, Ehlken
N, Fischer C, Reichenberger F, Rosenkranz S, Seyfarth HJ, Mayer E,
et al: Exercise training improves exercise capacity and quality of
life in patients with inoperable or residual chronic thromboembolic
pulmonary hypertension. PLoS One. 7(e41603)2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li L, Wang HM and Shen Y: Chinese SF-36
health survey: Translation, cultural adaptation, validation, and
normalisation. J Epidemiol Community Health. 57:259–263.
2003.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Spitzer RL, Kroenke K, Williams JB and
Löwe B: A brief measure for assessing generalized anxiety disorder:
The GAD-7. Arch Intern Med. 166:1092–1097. 2006.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kroenke K, Spitzer RL and Williams JB: The
PHQ-9: Validity of a brief depression severity measure. J Gen
Intern Med. 16:606–613. 2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Matura LA, McDonough A and Carroll DL:
Health-related quality of life and psychological states in patients
with pulmonary arterial hypertension. J Cardiovasc Nurs.
29:178–184. 2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
McCollister DH, Beutz M, McLaughlin V,
Rumsfeld J, Masoudi FA, Tripputi M, Yaeger T, Weintraub P and
Badesch DB: Depressive symptoms in pulmonary arterial hypertension:
Prevalence and association with functional status. Psychosomatics.
51:339–339.e8. 2010.PubMed/NCBI View Article : Google Scholar
|
|
21
|
White J, Hopkins RO, Glissmeyer EW,
Kitterman N and Elliott CG: Cognitive, emotional, and quality of
life outcomes in patients with pulmonary arterial hypertension.
Respir Res. 7(55)2006.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Buoli M, Caldiroli A, Serati M, Grassi S
and Altamura AC: Sex steroids and major psychoses: Which role for
DHEA-S and progesterone. Neuropsychobiology. 73:178–183.
2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Maurer J, Rebbapragada V, Borson S,
Goldstein R, Kunik ME, Yohannes AM and Hanania NA: ACCP Workshop
Panel on Anxiety and Depression in COPD: Anxiety and depression in
COPD: Current understanding, unanswered questions, and research
needs. Chest. 134 (4 Suppl):43S–56S. 2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhai Z, Zhou X, Zhang S, Xie W, Wan J,
Kuang T, Yang Y, Huang H and Wang C: The impact and financial
burden of pulmonary arterial hypertension on patients and
caregivers: Results from a national survey. Medicine (Baltimore).
96(e6783)2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
First MB, Spitzer RL, Gibbon M and
Williams JBW: Structured clinical interview for DSM.IV.TR axis I
disorders, research version, patient edition (SCID.I/P). New York:
Biometrics Research, New York State Psychiatric Institute,
2002.
|
|
26
|
Kam IW: Development of the bilingual
(Chinese/English) SCID-I (Structured Clinical Interview for DSM-IV
axis I disorder): A study of its reliability and validity in an
in-patient population (Dissertation for Part III Examination of
FHKCPsych) Hong Kong College of Psychiatrist, Hong Kong, 2000.
|
|
27
|
Kawut SM, Horn EM, Berekashvili KK,
Lederer DJ, Widlitz AC, Rosenzweig EB and Barst RJ: Selective
serotonin reuptake inhibitor use and outcomes in pulmonary arterial
hypertension. Pulm Pharmacol Ther. 19:370–374. 2006.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Sadoughi A, Roberts KE, Preston IR, Lai
GP, McCollister DH, Farber HW and Hill NS: Use of selective
serotonin reuptake inhibitors and outcomes in pulmonary arterial
hypertension. Chest. 144:531–541. 2013.PubMed/NCBI View Article : Google Scholar
|
